References
- WHO . Global tuberculosis report 2016 ( 2016 ). http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf .
- Lee JY . Diagnosis and treatment of extrapulmonary tuberculosis . Tuberc. Respir. Dis.78 ( 2 ), 47 – 55 ( 2015 ).
- Baijnath S Naiker S Shobo A et al. Evidence for the presence of clofazimine and its distribution in the healthy mouse brain . J. Mol. Histol.46 ( 4–5 ), 439 – 442 ( 2015 ).
- Baijnath S Shobo A Bester LA et al. Small molecule distribution in rat lung: a comparison of various cryoprotectants as inflation media and their applicability to MSI . J. Mol. Histol.47 ( 2 ), 213 – 219 ( 2016 ).
- Bratkowska D Shobo A Singh S et al. Determination of the antitubercular drug PA-824 in rat plasma, lung and brain tissues by liquid chromatography tandem mass spectrometry: application to a pharmacokinetic study . J. Chromatogr. B988 , 187 – 194 ( 2015 ).
- Munyeza CF Shobo A Baijnath S et al. Development and validation of a liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for the quantification of tigecycline in rat brain tissues . Biomed. Chromatogr.30 ( 6 ), 837 – 845 ( 2015 ).
- Shobo A Baijnath S Bratkowska D et al. MALDI MSI and LC–MS/MS: towards preclinical determination of the neurotoxic potential of fluoroquinolones . Drug Test. Anal.8 ( 8 ), 832 – 838 ( 2015 ).
- Shobo A Bratkowska D Baijnath S et al. Visualization of time-dependent distribution of rifampicin in rat brain using MALDI MSI and quantitative LCMS/MS . Assay Drug Dev. Technol.13 ( 5 ), 277 – 284 ( 2015 ).
- Shobo A Bratkowska D Baijnath S et al. Tissue distribution of pretomanid in rat brain via mass spectrometry imaging . Xenobiotica46 ( 3 ), 247 – 252 ( 2016 ).
- Tasneen R Williams K Amoabeng O et al. Contribution of the nitroimidazoles PA-824 and TBA-354 to the activity of novel regimens in murine models of tuberculosis . Antimicrob. Agents Chemother.59 ( 1 ), 129 – 135 ( 2015 ).
- Williams K Minkowski A Amoabeng O et al. Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis . Antimicrob. Agents Chemother.56 ( 6 ), 3114 – 3120 ( 2012 ).
- Warnken ZN Smyth HDC Watts AB Weitman S Kuhn JG Williams RO . Formulation and device design to increase nose to brain drug delivery . J. Drug Deliv. Sci. Technol.35 , 213 – 222 ( 2016 ).
- Velasco-Aguirre C Morales F Gallardo-Toledo E et al. Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches . Int. J. Nanomed.10 , 4919 – 4936 ( 2015 ).
- Sood S Jain K Gowthamarajan K . Intranasal therapeutic strategies for management of Alzheimer's disease . J. Drug Target.22 ( 4 ), 279 – 294 ( 2014 ).
- Sintov AC Velasco-Aguirre C Gallardo-Toledo E Araya E Kogan MJ . Metal nanoparticles as targeted carriers circumventing the blood–brain barrier . Int. Rev. Neurobiol.130 , 199 – 227 ( 2016 ).
- Rodriguez-Nogales C Garbayo E Carmona-Abellan MM Luquin MR Blanco-Prieto MJ . Brain aging and Parkinson's disease: new therapeutic approaches using drug delivery systems . Maturitas84 , 25 – 31 ( 2016 ).
- Meredith ME Salameh TS Banks WA . Intranasal delivery of proteins and peptides in the treatment of neurodegenerative diseases . AAPS J.17 ( 4 ), 780 – 787 ( 2015 ).
- Yadav S Gattacceca F Panicucci R Amiji MM . Comparative biodistribution and pharmacokinetic analysis of cyclosporine-A in the brain upon intranasal or intravenous administration in an oil-in-water nanoemulsion formulation . Mol. Pharm.12 ( 5 ), 1523 – 1533 ( 2015 ).
- Meredith ME Salameh TS Banks WA . Intranasal delivery of proteins and peptides in the treatment of neurodegenerative diseases . AAPS J.17 ( 4 ), 780 – 787 ( 2015 ).
- Vyas TK Shahiwala A Amiji MM . Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations . Int. J. Pharm.347 ( 1 ), 93 – 101 ( 2008 ).
- Shah L Gattacceca F Amiji MM . CNS delivery and pharmacokinetic evaluations of DALDA analgesic peptide analog administered in nanosized oil-in-water emulsion formulation . Pharm. Res.31 ( 5 ), 1315 – 1324 ( 2014 ).
- Tiwari SB Amiji MM . Improved oral delivery of paclitaxel following administration in nanoemulsion formulations . J. Nanosci. Nanotechnol.6 ( 9–1 ), 3215 – 3221 ( 2006 ).
- Wang L Ma Y Duan H et al. Pharmacokinetics and tissue distribution study of PA-824 in rats by LC–MS/MS . J. Chromatogr. B1006 , 194 – 200 ( 2015 ).
- Xia X Pethe K Kim R et al. Encapsulation of anti-tuberculosis drugs within mesoporous silica and intracellular antibacterial activities . Nanomaterials4 ( 3 ), 813 – 826 ( 2014 ).
- Sung JC Garcia-Contreras L Verberkmoes JL et al. Dry powder nitroimidazopyran antibiotic PA-824 aerosol for inhalation . Antimicrob. Agents Chemother.53 ( 4 ), 1338 – 1343 ( 2009 ).
- Kozlovskaya L Abou-Kaoud M Stepensky D . Quantitative analysis of drug delivery to the brain via nasal route . J. Control. Rel.189 , 133 – 140 ( 2014 ).
- Drin G Cottin S Blanc E Rees AR Temsamani J . Studies on the internalization mechanism of cationic cell-penetrating peptides . J. Biol. Chem.278 ( 33 ), 31192 – 31201 ( 2003 ).
- Teklezgi BG Pamreddy A Baijnath S et al. Post heroin dose tissue distribution of 6-monoacetylmorphine (6-MAM) with MALDI imaging . J. Mol. Histol.48 ( 4 ), 285 – 292 ( 2017 ).
- Teklezgi BG Pamreddy A Baijnath S et al. Time dependent regional brain distribution of methadone and naltrexone in the treatment of opioid addiction . Addict. Biol. doi:10.1111/adb.12609 ( 2018 )( Epub ahead of print ).
- Nau R Sörgel F Eiffert H . Penetration of drugs through the blood–cerebrospinal fluid/blood–brain barrier for treatment of central nervous system infections . Clin. Microbiol. Rev.23 ( 4 ), 858 – 883 ( 2010 ).
- Liu L Xu Y Shea C Fowler JS Hooker JM Tonge PJ . Radiosynthesis and bioimaging of the tuberculosis chemotherapeutics isoniazid, rifampicin and pyrazinamide in baboons . J. Med. Chem.53 ( 7 ), 2882 ( 2010 ).
- Ahmad Z Peloquin CA Singh RP et al. PA-824 exhibits time-dependent activity in a murine model of tuberculosis . Antimicrob. Agents Chemother.55 ( 1 ), 239 – 245 ( 2011 ).
- Stover CK Warrener P Vandevanter DR et al. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis . Nature405 ( 6789 ), 962 – 966 ( 2000 ).
- Graff CL Pollack GM . P-Glycoprotein attenuates brain uptake of substrates after nasal instillation . Pharm. Res.20 ( 8 ), 1225 – 1230 ( 2003 ).